Today in Science
SEE OTHER BRANDS

Fresh science news from the world

Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on May 1, 2025

Volatus annonce la clôture d'un placement VIE entièrement souscrit de 3 000 000 $

Volatus annonce la clôture d'un placement VIE entièrement souscrit de 3 000 000 $

Ne pas distribuer aux agences de presse des États-Unis ni diffuser aux États-Unis. TORONTO, 01 mai 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV :FLT) (OTCQX :TAKOF) (Francfort : ABB) (« Volatus » ou la « Société ») est heureuse d'annoncer qu'elle …

THINK AGENT STANDARD LAUNCHES WITH SUPPORT FROM 70+ COMPANIES TO CHALLENGE BIG TECH’S AI MONOPOLY

THINK AGENT STANDARD LAUNCHES WITH SUPPORT FROM 70+ COMPANIES TO CHALLENGE BIG TECH’S AI MONOPOLY

SEATTLE, WA, May 01, 2025 (GLOBE NEWSWIRE) -- Thinkagents.ai is proud to announce the beta launch of the Think Agent Standard, a foundational framework for enabling millions of autonomous, on-chain AI agents to transact and communicate. Developed by the …

Volatus Announces Closing of Fully Subscribed LIFE Offering of $3,000,000

Volatus Announces Closing of Fully Subscribed LIFE Offering of $3,000,000

Not for distribution to United States newswire services or for dissemination in the United States. TORONTO, May 01, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV:FLT) (OTCQX:TAKOF) (Frankfurt: ABB) (“Volatus” or the “Company”) is pleased to …

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor …

Altai Announces Initiation of Strategic Review

Altai Announces Initiation of Strategic Review

TORONTO, May 01, 2025 (GLOBE NEWSWIRE) -- Altai Resources Inc. (TSXV: ATI) (“Altai” or the “Company”) announced today that the Board of Directors (the “Board”) has initiated a strategic review process to identify, evaluate, and pursue a range of potential …

Rumble Announces Timing of First Quarter 2025 Earnings Release and Conference Call

Rumble Announces Timing of First Quarter 2025 Earnings Release and Conference Call

LONGBOAT KEY, FL, May 01, 2025 (GLOBE NEWSWIRE) -- Rumble Inc. (NASDAQ: RUM) (“Rumble” or the “Company”), the video-sharing platform and cloud services provider, today announced that it will release financial results for the fiscal quarter ended March 31, …

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

DEER PARK, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will …

Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure

Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure

WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician- …

MacroGenics to Participate in Upcoming Investor Conference

MacroGenics to Participate in Upcoming Investor Conference

ROCKVILLE, MD, May 01, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today …

Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K

Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K

CARLSBAD, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC …

Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights

Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights

– Company advances SL-325 program with an IND filing expected in the third quarter of 2025 – – Cash balance of approximately $60.9 million as of March 31, 2025, expected to fund operations into 2027 – AUSTIN, TX and DURHAM, NC, May 01, 2025 (GLOBE NEWSWIRE …

Astera Labs Ramps Production of PCIe 6 Connectivity Portfolio Supercharging Advanced AI and Cloud Infrastructure Deployments

Astera Labs Ramps Production of PCIe 6 Connectivity Portfolio Supercharging Advanced AI and Cloud Infrastructure Deployments

SANTA CLARA, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced its purpose-built PCIe® 6 connectivity portfolio is …

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FLORHAM PARK, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in …

Mercury Acquires Star Lab to Advance Its Leadership Position in Secure Processing

Mercury Acquires Star Lab to Advance Its Leadership Position in Secure Processing

ANDOVER, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a technology company that delivers mission-critical processing to the edge, today announced the closure of an agreement that will further advance the …

Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy

Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy

SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) action date for the New Drug …

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

iRhythm Zio® Long-Term Continuous Monitoring (LTCM) system — commercially introduced in Japan as the Zio® ECG Recording and Analysis System — brings AI-powered, continuous, uninterrupted ECG monitoring for up to 14 days to Japan Launch is timely amid a …

iRhythmは、日本においてZio ECG記録・解析システムとしてZio®長期連続モニタリング サービスを開始し、AIを活用した不整脈検出の進化を推進します。

iRhythmは、日本においてZio ECG記録・解析システムとしてZio®長期連続モニタリング サービスを開始し、AIを活用した不整脈検出の進化を推進します。

日本で「Zio ECG記録・解析システム」として商業的に導入されたiRhythm Zio®長期連続心電図モニタリングサービスは、AIを活用した連続的で中断のない心電図モニタリングを最長14日間提供します。 日本における不整脈の早期かつ正確な検出に対する需要が高まる中、本製品の発売は適切なタイミングです。日本は世界第2位の携帯型/ 装着型心電計市場であり、高齢化に伴い不整脈の有病率が上昇すると予想されています1-3。   サンフランシスコ, May 01, 2025 (GLOBE NEWSWIRE) -- …

Nutanix Announces Date and Conference Call Information for Third Quarter Fiscal Year 2025 Financial Results

Nutanix Announces Date and Conference Call Information for Third Quarter Fiscal Year 2025 Financial Results

SAN JOSE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that it will report its financial results for the third quarter of fiscal year 2025, which ended April 30, 2025, after …

Sutro Biopharma to Participate in Upcoming Investor Conferences

Sutro Biopharma to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that management will …

Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference

Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference

REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be presenting at the Bank of America Securities …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service